Last reviewed · How we verify

NCT03482999

Case Series Assessing TissuGlu® Surgical Adhesive in Flap Surgery for Decubitus Repair

Completed Last updated 29 March 2018
What this trial tests

trial testing TissuGlu Surgical Adhesive in Decubitus Ulcer in 50 participants. Completed in 27 August 2015.

Timeline
28 March 2011
Primary endpoint
27 August 2015
27 August 2015

Quick facts

Lead sponsorCohera Medical, Inc.
StatusCompleted
Study typeOBSERVATIONAL
Enrollment50
Start date28 March 2011
Primary completion27 August 2015
Estimated completion27 August 2015

Drugs / interventions tested

Conditions studied

Sponsor

Cohera Medical, Inc.

Who can join

Eligibility, any sex, with Decubitus Ulcer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the impact of a high strength lysine-based adhesive (TissuGlu® Surgical Adhesive) on complications and revision rates in large flap surgery for decubitus repair.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of TissuGlu Surgical Adhesive

Trials testing the same drug.

Other Cohera Medical, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03482999.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing